These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 18565023

  • 1. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
    Yamamoto Y, Ono T, Dhar DK, Yamanoi A, Tachibana M, Tanaka T, Nagasue N.
    J Gastroenterol Hepatol; 2008 Jun; 23(6):930-7. PubMed ID: 18565023
    [Abstract] [Full Text] [Related]

  • 2. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 3. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 4. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J, Kim BH, Kim YI, Kim KY, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW, Chang R.
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C, Liu H, Posch MG, Waechter M, Facklam M, Fenner MH, Ruthardt M, Possinger K, Phillip Koeffler H, Elstner E.
    Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J, Sterz J, Krebbel H, Zavrski I, Kaiser M, Zang C, Heider U, Jakob C, Elstner E, Sezer O.
    Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
    [Abstract] [Full Text] [Related]

  • 7. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats.
    Zhao X, Zhang Y, Strong R, Grotta JC, Aronowski J.
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):811-20. PubMed ID: 16208315
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 9. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
    Yuan J, Takahashi A, Masumori N, Uchida K, Hisasue S, Kitamura H, Itoh N, Tsukamoto T.
    Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
    [Abstract] [Full Text] [Related]

  • 10. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z, Ye P, Long C, Chen K, Li X, Wang H.
    Pharmacology; 2007 Mar; 79(3):184-92. PubMed ID: 17356310
    [Abstract] [Full Text] [Related]

  • 11. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE, Gould H, Harris T, Bonacci JV, Stewart AG.
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C, Landreth GE, Sastre M, Beck M, Feinstein DL, Jacobs AH, Schlegel U, Heneka MT.
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [Abstract] [Full Text] [Related]

  • 13. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC.
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma.
    Ota K, Ito K, Suzuki T, Saito S, Tamura M, Hayashi S, Okamura K, Sasano H, Yaegashi N.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4200-8. PubMed ID: 16857792
    [Abstract] [Full Text] [Related]

  • 15. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN, Lee YR, Noh EM, Lee KS, Kim JS, Song EK, Han MK, Lee YC, Kwon KB, Lee SJ, Youn HJ, Jung SH.
    Cell Biol Int; 2008 Aug 15; 32(8):906-12. PubMed ID: 18474441
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D, Yoshihiro H, Nakanishi M, Naruyama H, Okada S, Ando R, Tozawa K, Kohri K.
    Cancer Detect Prev; 2008 Aug 15; 32(3):259-66. PubMed ID: 18789607
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
    Cheng J, Nakamura H, Imanishi H, Liu W, Morisaki T, Sugiyama T, Hada T.
    Biochem Biophys Res Commun; 2004 Sep 17; 322(2):458-64. PubMed ID: 15325252
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.
    Yasugi E, Horiuchi A, Uemura I, Okuma E, Nakatsu M, Saeki K, Kamisaka Y, Kagechika H, Yasuda K, Yuo A.
    Dev Growth Differ; 2006 Apr 17; 48(3):177-88. PubMed ID: 16573735
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R.
    Shock; 2009 Sep 17; 32(3):317-24. PubMed ID: 19174742
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of curcumin on early liver regeneration following partial hepatectomy in rats.
    Seehofer D, Schirmeier A, Bengmark S, Carter J, Koch M, Glanemann M, Nüssler AK, Neuhaus P, Menger MD.
    J Surg Res; 2009 Aug 17; 155(2):195-200. PubMed ID: 19482305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.